Low testosterone levels are associated with endothelial dysfunction in oophorectomized early postmenopausal women

European Journal of Endocrinology

Volumn 174, Issue 3, 2016, Pages 297-306

  Rech, Ciciliana Maila Zilio ^a   Clapauch, Ruth ^a,b   De Souza, Maria Das Gracas Coelho ^a   Bouskela, Eliete ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b HOSPITAL DA LAGOA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; GLYCERYL TRINITRATE; TESTOSTERONE; VASCULAR CELL ADHESION MOLECULE 1; ANDROSTENEDIONE; CHOLESTEROL; ESTROGEN; ESTRONE; FOLLITROPIN; GLUCOSE BLOOD LEVEL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PRASTERONE SULFATE; SERUM ALBUMIN; SEX HORMONE BINDING GLOBULIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BIOCHEMISTRY; BODY COMPOSITION; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM DEPENDENT FLOW MEDIATED DILATATION; ENDOTHELIUM INDEPENDENT DILATION; ESTROGEN THERAPY; FEMALE; FOREARM BLOOD FLOW; HORMONE DETERMINATION; HUMAN; HYPEREMIA; INFLAMMATION; MAJOR CLINICAL STUDY; METABOLISM; MIDDLE AGED; OVARIECTOMY; POSTMENOPAUSE; PRIORITY JOURNAL; RADIODENSITOMETRY; VASCULAR CAPACITY; VEIN OCCLUSION PLETHYSMOGRAPHY; X RAY SPECTROMETRY; BLOOD; CASE CONTROL STUDY; GLUCOSE BLOOD LEVEL; HYPOGONADISM; IMPEDANCE PLETHYSMOGRAPHY; PATHOPHYSIOLOGY; PHOTON ABSORPTIOMETRY; PHYSIOLOGY; PLETHYSMOGRAPHY; VASCULAR ENDOTHELIUM; VASODILATATION;

ABSORPTIOMETRY, PHOTON; ANDROSTENEDIONE; BLOOD GLUCOSE; CASE-CONTROL STUDIES; CHOLESTEROL; CHOLESTEROL, HDL; DEHYDROEPIANDROSTERONE SULFATE; ENDOTHELIUM, VASCULAR; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; ESTRONE; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; HYPOGONADISM; MIDDLE AGED; OVARIECTOMY; PLETHYSMOGRAPHY; PLETHYSMOGRAPHY, IMPEDANCE; POSTMENOPAUSE; SERUM ALBUMIN; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE; TRIGLYCERIDES; VASCULAR CELL ADHESION MOLECULE-1; VASODILATION;

EID: 84958267659     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-15-0878     Document Type: Article

References (42)

1. Maturana MA, Irigoyen MC & Spritzer PM. Menopause, estrogens, and endothelial dysfunction: current concepts. Clinics 2007 62 77-86. (doi:10.1590/S1807-59322007000100012)
2. Kalantaridou SN, Naka KK, Papanikolaou E, Kazakos N, Kravariti M, Calis KA, Paraskevaidis EA, Sideris DA, Tsatsoulis A, Chrousos GP et al. Impaired endothelial function in young women with premature ovarian failure: normalization with hormone therapy. Journal of Clinical Endocrinology and Metabolism 2004 89 3907-3913. (doi:10.1210/jc. 2004-0015)
3. Caramori PR & Zago A. Disfunção endotelial e doença arterial coronariana. Arquivos Brasileiros de Cardiologia 2000 75 163-172. (doi:10.1590/S0066-782X2000000800009)
4. Davison SL, Bell R, Donath S, Montalto JG & Davis S.R. Androgen levels in adult females: changes with age, menopause, and oophorectomy. Journal of Clinical Endocrinology and Metabolism 2005 90 3847-3853. (doi:10.1210/jc.2005-0212)
5. Keshavarz H, Hillis SD, Kieke BA & Marchbanks PA. Hysterectomy surveillance-United States, 1994-1999. Morbidity and Mortality Weekly Report. Surveillance Summaries 2002 51 1-8.
6. Mai PL, Wentzensen N & Greene MH. Challenges related to developing serum-based biomarkers for early ovarian cancer detection. Cancer Prevention Research 2011 4 303-306. (doi:10.1158/1940-6207.CAPR-11-0053)
7. Jemal A, Bray F, Center MM, Ferlay J, Ward E & Forman D. Global cancer statistics. CA A Cancer Journal for Clinicians 2011 61 69-90. (doi:10.3322/caac.20107)
8. Wygoda M, Filippo RB Jr, Gomes MA & Clapauch R. Monitorizando a terapia de reposição estrogênica (TRE) na menopausa. Arquivos Brasileiros de Endocrinologia e Metabologia 1999 43 336-343. (doi:10.1590/S0004-27301999000500005)
9. Friedewald WT, Levy RI & Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry 1972 18 499-502.
10. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF & Turner RC. Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 412-419. (doi:10.1007/BF00280883)
11. Vermeulen A, Verdonck L & Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serumA critical evaluation of simple methods for the estimation of free testosterone in serum. Journal of Clinical Endocrinology and Metabolism 1999 84 3666-3672. (doi:10.1210/jcem.84.10.6079)
12. World Health Organ Tech Rep Ser. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organization Technical Report Series 2000 894 1-253.
13. Bachrach LK. Dual energy X-ray absorptiometry (DEXA) measurements of bone density and body composition: promise and pitfalls. Journal of Pediatric Endocrinology & Metabolism 2000 13 983-988.
14. Hangartner TN, Warner S, Braillon P, Jankowski L & Shepherd J. The official positions of the International Society for Clinical Densitometry: acquisition of dual-energy X ray absorptiometry body composition and considerations regarding analysis and repeatability of measures. Journal of Clinical Densitometry 2013 16 520-536. (doi:10.1016/j.jocd. 2013.08.007)
15. Petak S, Barbu CG, Yu EW, Fielding R, Mulligan K, Sabowitz B, Wu CH & Shepherd JA. The official positions of the international society for clinical densitometry: body composition analysis reporting. Journal of Clinical Densitometry 2013 16 508-519. (doi:10.1016/j.jocd. 2013.08.018)
16. Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg P, Elia M, Gómez JM, Heitmann BL, Kent-Smith L, Melchior JC, Pirlich M et al. Composition of the ESPEN Working Group. Bioelectrical impedance analysis-part I: review of principles and methodsComposition of the ESPEN Working Group. Clinical Nutrition 2004 23 1226-1243. (doi:10.1016/j.clnu.2004. 06.004)
17. Alomari MA, Solomito A, Reyes R, Khalil SM, Wood RH & Welsch M.A. Plethysmography: technical considerations, standardization and physiological findings. American Journal of Physiology. Heart and Circulatory Physiology 2004 286 99-107. (doi:10.1152/ajpheart.00529. 2003)
18. Vita JA & Keaney JF. Endothelial function: a barometer for cardiovascular risk? Circulation 2002 106 640-642. (doi:10.1161/01.CIR. 0000028581.07992.56)
19. The World Health Report 2004: Changing History. Geneva, World Health Organization 2004.
20. Clapauch R, Mecenas AS, Maranhão PA & Bouskela E. Early postmenopausal women with cardiovascular risk factors improve microvascular dysfunction after acute estradiol administration. Menopause 2012 19 672-679. (doi:10.1097/gme.0b013e31823a8f43)
21. Joannides R, Haefeli WE, Linder L, Richard V, Bakkali EH, Thuillez C & Lüscher TF. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 1995 91 1314-1319. (doi:10.1161/01.CIR.91.5.1314)
22. Oliver JJ & Webb DJ. Noninvasive assessment of arterial stiffness and risk of atherosclerotic events. Arteriosclerosis, Thrombosis, and Vascular Biology 2003 23 554-566. (doi:10.1161/01.ATV.0000060460.52916.D6)
23. Allison MA, Manson JE, Langer RD, Carr JJ, Rossouw JE, Pettinger MB, Phillips L, Cochrane BB, Eaton CB, Greenland P et al. Women's Health Initiative and Women's Health Initiative Coronary Artery Calcium Study Investigators, oophorectomy, hormone therapy, and subclinical coronary artery disease in women with hysterectomy: the Women's Health Initiative coronary artery calcium study. Menopause 2008 15 639-647. (doi:10.1097/gme.0b013e31816d5b1c)
24. Dørum A, Tonstad S, Liavaag AH, Michelsen TM, Hildrum B & Dahl AA. Bilateral oophorectomy before 50 years of age is significantly associated with the metabolic syndrome and Framingham risk score: a controlled, population-based study (HUNT-2). Gynecologic Oncology 2008 109 377-383.
25. Montalcini T, Gorgone G, Gazzaruso C, Sesti G, Perticone F & Pujia A. Endogenous testosterone and endothelial function in postmenopausal women. Coronary Artery Disease 2007 18 9-13. (doi:10.1097/01.mca. 0000236290.79306.d1)
26. Worboys S, Kotsopoulos D, Teede H, McGrath B & David S.R. Evidence that parenteral testosterone therapy may improve endothelium-dependent and independent vasodilatation in postme-nopausal women already receiving estrogen. Journal of Clinical Endocrinology and Metabolism 2001 88 158-161. (doi:10.1210/jcem.86. 1.7103)
27. Wu FCW & von Eckardstein A. Androgens and coronary artery disease. Endocrine Reviews 2003 24 183-217. (doi:10.1210/er.2001-0025)
28. Harada N, Sasano H, Murakami H, Ohkuma T, Nagura H & Takagi Y. Localized expression of aromatase in human vascular tissues. Circulation Research 1999 84 1285-1291. (doi:10.1161/01.RES.84. 11.1285)
29. Studd J. Variations on hormone replacement therapy: an answer to the 'one dose fits all' Women's Health Initiative study. Gynecological Endocrinology 2007 23 665-671. (doi:10.1080/09513590701671878)
30. Davison SL, Bell R, Donath S, Montalto JG & Davis S.R. Androgen levels in adult females: changes with age, menopause, and oophorectomy. Journal of Clinical Endocrinology and Metabolism 2005 90 3847-3853. (doi:10.1210/jc.2005-0212)
31. Fogle RH, Stanczyk FZ, Zhang X & Paulson RJ. Postmenopausal ovarian androgen production. Journal of Clinical Endocrinology and Metabolism 2007 92 3040-3043. (doi:10.1210/jc.2007-0581)
32. McCarthy AM, Menke A & Visvanathan K. Association of bilateral oophorectomy and body fatness in a representative sample of US women. Gynecologic Oncology 2013 129 559-564. (doi:10.1016/j.ygyno. 2013.02.016)
33. Chalvatzas N, Dafopoulos K, Kosmas G, Kallitsaris A, Pournaras S & Messinis IE. Effect of ovarian hormones on serum adiponectin and resistin concentrations. Fertility and Sterility 2009 91 1189-1194. (doi:10.1016/j.fertnstert.2008.01.027)
34. Cybulsky MI, Iiyama K, Li H, Zhu S, Chen M, Iiyama M, Davis V, Gutierrez-Ramos JC, Connelly PW & Milstone DS. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. Journal of Clinical Investigation 2001 107 1255-1262. (doi:10.1172/JCI11871)
35. Libby P, Ridker PM & Maseri A. Inflammation and atherosclerosis. Circulation 2002 105 1135-1143. (doi:10.1161/hc0902.104353)
36. Mukherjee TK, Dinh H, Chaudhuri G & Nathan L. Testosterone attenuates expression of vascular cell adhesion molecule-1 by conversion to estradiol by aromatase in endothelial cells: Implications in atherosclerosis. PNAS 2002 99 4055-4060. (doi:10.1073/pnas. 052703199)
37. Yilmaz SA, Kebapcilar A, Koplay M, Kerimoglu OS, Pekin AT, Gencoglu B, Dogan NU & Celik C. Association of clinical androgen excess with radial artery intima media thickness in women with polycystic ovary syndrome. Gynecological Endocrinology 2015 6 477-482. (doi:10.3109/09513590.2015.1014783)
38. Laughlin GA, Goodell V & Barrett-Connor E. Extremes of endogenous testosterone are associated with increased risk of incident coronary events in older women. Journal of Clinical Endocrinology and Metabolism 2010 95 740-747. (doi:10.1210/jc.2009-1693)
39. Livadas S, Pappas C, Karachalios A, Marinakis E, Tolia N, Drakou M, Kaldrymides P, Panidis D & Diamanti-Kandarakis E. Prevalence and impact of hyperandrogenemia in 1, 218 women with polycystic ovary syndrome. Endocrine 2014 47 631-638. (doi:10.1007/s12020-014-0200-7)
40. Pertynska-Marczewska M, Diamanti-Kandarikis E, Zhang J & Merhi Z. Advanced glycation end products: a link between metabolic and endothelial dysfunction in polycystic ovary syndrome? Metabolism 2015 64 1564-1573. (doi:10.1016/j.metabol.2015.08.010)
41. Diamanti-Kandarakis E, Lambrinoudaki I, Economou F, Christou M, Piperi C, Papavassiliou AG & Creatsas G. Androgens associated with advanced glycation end-products in postmenopausal women. Menopause 2010 17 1182-1187. (doi:10.1097/gme.0b013e3181e170af)
42. Huang G, Tang E, Aakil A, Anderson S, Jara H, Davda M, Stroh H, Travison TG, Bhasin S & Basaria S. Testosterone dose-response relationships with cardiovascular risk markers in androgen-deficient women: a randomized, placebo-controlled trial. Journal of Clinical Endocrinology and Metabolism 2014 99 1287-1293. (doi:10.1210/jc.2013-4160)